899 related articles for article (PubMed ID: 19805956)
21. Prevalence of Candida dubliniensis among germ tube-positive Candida isolates in a maternity hospital in Kuwait.
Al-Sweih N; Ahmad S; Khan ZU; Khan S; Chandy R
Mycoses; 2005 Sep; 48(5):347-51. PubMed ID: 16115107
[TBL] [Abstract][Full Text] [Related]
22. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and antifungal resistance profile of Candida spp. oral isolates from patients with type 1 and 2 diabetes mellitus.
Bremenkamp RM; Caris AR; Jorge AO; Back-Brito GN; Mota AJ; Balducci I; Brighenti FL; Koga-Ito CY
Arch Oral Biol; 2011 Jun; 56(6):549-55. PubMed ID: 21183157
[TBL] [Abstract][Full Text] [Related]
24. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
25. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals.
Zaoutis TE; Foraker E; McGowan KL; Mortensen J; Campos J; Walsh TJ; Klein JD
Diagn Microbiol Infect Dis; 2005 Aug; 52(4):295-8. PubMed ID: 15922535
[TBL] [Abstract][Full Text] [Related]
26. A longitudinal study of the change in resistance patterns and genetic relationship of oral Candida albicans from HIV-infected patients.
McCullough M; Hume S
J Med Vet Mycol; 1995; 33(1):33-7. PubMed ID: 7650576
[TBL] [Abstract][Full Text] [Related]
27. Rapid identification of fluconazole resistance using Chromagar Candida.
Verghese SL; Padmaja P; Sutha P; Mathew T; John ES
Indian J Pathol Microbiol; 2000 Jul; 43(3):343-6. PubMed ID: 11218683
[TBL] [Abstract][Full Text] [Related]
28. Candida dubliniensis at a cancer center.
Sebti A; Kiehn TE; Perlin D; Chaturvedi V; Wong M; Doney A; Park S; Sepkowitz KA
Clin Infect Dis; 2001 Apr; 32(7):1034-8. PubMed ID: 11264031
[TBL] [Abstract][Full Text] [Related]
29. Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients.
Bussaratid V; Tansupasawasdikul S; Simpson A; Pitisuttithum P; Phonrat B; Howe P; White NJ
J Med Assoc Thai; 2002 Jul; 85(7):757-64. PubMed ID: 12296406
[TBL] [Abstract][Full Text] [Related]
30. Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patients.
Badiee P; Alborzi A; Davarpanah MA; Shakiba E
Arch Iran Med; 2010 Jul; 13(4):282-7. PubMed ID: 20597560
[TBL] [Abstract][Full Text] [Related]
31. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.
Moran GP; Sullivan DJ; Henman MC; McCreary CE; Harrington BJ; Shanley DB; Coleman DC
Antimicrob Agents Chemother; 1997 Mar; 41(3):617-23. PubMed ID: 9056003
[TBL] [Abstract][Full Text] [Related]
32. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
[TBL] [Abstract][Full Text] [Related]
33. [Candida dubliniensis studies and isolation of Candida types in oropharyngeal specimens from oncologic patients].
Tekeli A; Dolapçi I; Cesur S; Tekeli E; Içli F
Mikrobiyol Bul; 2002 Jan; 36(1):57-63. PubMed ID: 12476767
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal genotyping of Candida dubliniensis isolates reveals strain maintenance, microevolution, and the emergence of itraconazole resistance.
Fleischhacker M; Pasligh J; Moran G; Ruhnke M
J Clin Microbiol; 2010 May; 48(5):1643-50. PubMed ID: 20200288
[TBL] [Abstract][Full Text] [Related]
35. Differentiation of Candida dubliniensis on chrom agar and Pal's agar.
Raut SH; Varaiya A
Indian J Med Microbiol; 2009; 27(1):55-8. PubMed ID: 19172062
[TBL] [Abstract][Full Text] [Related]
36. Multiple oral Candida infections in patients with Sjogren's syndrome -- prevalence and clinical and drug susceptibility profiles.
Yan Z; Young AL; Hua H; Xu Y
J Rheumatol; 2011 Nov; 38(11):2428-31. PubMed ID: 21844143
[TBL] [Abstract][Full Text] [Related]
37. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
[TBL] [Abstract][Full Text] [Related]
38. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
Belazi M; Velegraki A; Koussidou-Eremondi T; Andreadis D; Hini S; Arsenis G; Eliopoulou C; Destouni E; Antoniades D
Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
Xu Y; Chen L; Li C
J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina.
Jewtuchowicz VM; Mujica MT; Brusca MI; Sordelli N; Malzone MC; Pola SJ; Iovannitti CA; Rosa AC
Oral Microbiol Immunol; 2008 Dec; 23(6):505-9. PubMed ID: 18954358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
